Background and aims-To compare extracorporeal shock wave lithotripsy (ESWL) and laser induced shock wave lithotripsy (LISL) of retained bile duct stones to stone free rate, number of therapeutic sessions, and costs. Patients-Thirty four patients were randomly assigned to either ESWL or LISL therapy. The main reasons for failure of standard endoscopy were due to stone impaction (n=12), biliary stricture (n=8), or large stone diameter (n=14 (Gut 1997; 40: 678-682) 
Since the introduction of endoscopic sphincterotomy in 1974,' 2 endoscopy has been widely used in the treatment of common bile duct stones. Particularly in elderly patients, after previous cholecystectomy and before laparoscopic cholecystectomy, endoscopic bile duct clearance is preferred.3 Successful removal of bile duct stones by standard endoscopy was achieved in 85% to 95% of patients in several series. 4 For the remaining 5% to 15% of stones mechanical lithotripsy is the first line treatment with a therapeutic success of about 80% to 97% and the best reported cost effectiveness. This method fails in a few patients because the calculi are too large, impacted, or located above a biliary stricture. 5 Biliary stones are resistant to the above methods in only 2% to 5% of patients. For this selected group extracorporeal and various intracorporeal lithotripsy procedures were developed over the past decade."5 Laser lithotripsy is the latest development in the field of fragmentation techniques. A major problem in using this device is the requirement of cholangioscopic guidance, which is expensive due to the cost of the cumbersome endoscopic equipment and the need for two experienced endoscopists operating the "mother and baby" endoscope. 9 The most promising laser lithotripter has an integrated stone tissue detection system,10 which can be used under sole fluoroscopic guidance and thereby should reduce the expense of this means of fragmentation.
The aim of our prospective trial was to compare ultrasonically guided extracorporeal shock wave lithotripsy (ESWL) with laser induced intracorporeal lithotripsy (LISL) performed under pure radiological control, chiefly with respect to stone free rates, but also the number of endoscopic sessions necessary for therapeutic success, the side effects, and costs.
Methods
Over a two year period 34 patients with complicated bile duct stones were prospectively and randomly enrolled in the study (Table I) .
Inclusion criteria were as follows: (1) choledochal lithiasis, diagnosed by means of endoscopic retrograde cholangiography, (2) detection of the bile duct stones by abdominal ultrasound, (3) papilla within reach of the For LISL we used the Xenon flashlamp pulsed rhodamine 6G laser with an integrated stone tissue detection system (Lithognost, Carl Baasel Lasertechnik, Starnberg, Germany). The stone tissue detection system, as described elsewhere,'0 is based on the analysis of the back scattered laser energy. If the intensity of the light is below a defined threshold level, it indicates that the glass fibre is not in contact with a bile duct stone and the laser pulse is cut off with the aid of a polariser preventing tissue from being damaged."
The laser glass fibre (250 ,um or 300 pum core diameter) was inserted in a 5 Fr or 7 Fr gauge Huibregtse or balloon catheter and passed through the papilla via the working channel of a standard duodenoscope (Olympus JF 1-T20 (17) were visible by the integrated ultrasound scanner before therapy. Patients were treated with a mean of (1-24) ESWL sessions corresponding to a mean number of 10000 (1800-19 500) shock wave pulses. To achieve complete duct clearance a mean of 1 6 (0-7) additional sessions of endoscopic retrograde 60akobs, Adamek, Maier, Krdmer, Benz, Martin, Riemann cholangiopancreatography were necessary. Mean duration of hospital stay was 13-4 (4-8) days; mean interval between first ESWL and discharge from the hospital was 6&2 (2 2) days.
In nine of the 17 patients (53%) complete stone fragmentation using ESWL was achieved and was followed by the extraction of remaining fragments in one additional endoscopic retrograde cholangiopancreatography session. In three out of 17 patients stones were only partially fragmented; in five of the 17 patients (29-4%) there was no major fragmentation effect. Finally, in eight of 17 patients further fragmentation techniques were required.
The reasons for failure of ESWL therapy were as follows: loss of sonographic visibility of the bile stone during the procedure (three patients), or no fragmentation (n=2), or an unsatisfactory (n=3) fragmentation effect probably due to the stability of the stones.
In four patients electrohydraulic lithotripsy was used. Two of those became stone free.
In three patients fluoroscopic guided LISL was performed because of insufficient stone fragmentation during ESWL; stones were removed completely in two of these patients.
In the end, 14 of 17 (82.4%) patients were stone free after ESWL alone (nine of 17) or in combination with other methods (five of 17) in the ESWL group.
One of the patients with stones resistant to the endoscopic fragmentation techniques was sent to the surgical department to clear her bile ducts during cholecystectomy. The remaining two patients (ages 92 and 81 years) were treated by endoprosthesis insertion because they were poor candidates for operation due to coexisting diseases.
Some minor complications were noticed in the ESWL group: one patient reported pain despite intravenous sedoanalgesia; one patient had a vagovasal reaction (hypotension, dizziness) which necessitated stopping the ESWL session (the patient became stone free after the next ESWL session). One patient developed small skin petechiae immediately after ESWL.
The treatment related mortality was zero in the ESWL group. LISL 
GROUP
The seventeen patients of the LISL group were treated by a mean of 1 29 (0 46) LISL sessions and 3744 (800-21 241) correctly targeted pulses corresponding to a total number of 5300 (1440-22 831) laser pulses. The average stone detection rate (ratio of correctly targeted pulses to the total number of pulses) was about 68% with a slight but not significant increase as the study period progressed.
In combination with standard extraction manoeuvres using balloon catheters or baskets 14 of the 17 (82-4%0) patients became stone free with fluoroscopic guided LISL. Nine of these 14 patients were stone free in the same session; in five of them one additional endoscopic retrograde cholangiopancreatography session was necessary because the patients tolerated no further extraction manoeuvres (due to the duration of the preceeding LISL therapy). Overall, 0-65 (0 68) additional endoscopic retrograde cholangiopancreatography sessions per patient were necessary to clear the bile ducts completely.
The average hospital stay was 12-6 (7) days in this group; the mean period between first LISL and discharge from hospital was 3-5 (3 3) days.
In three of the 17 patients LISL failed. In two of them a sufficient fibre stone contact was not achievable due to a parapapillary diverticula and an unusually dilated distal common bile duct; both patients became stone free after ultrasonically guided ESWL. In one patient only a partial stone fragmentation was achieved; he was successfully treated by mechanical lithotripsy. Combined with additional fragmentation modalities stones were removed successfully in all 17 patients (100%) in the LISL group.
Complications due to laser therapy were as follows: one patient had an episode of acute cholangitis, and one patient complained of pain during LISL (despite intravenous analgesia). In three patients small amounts of blood were oozing from the papilla after pushing the glass fibre out of the endoscopic retrograde cholangiopancreatography catheter. However, bleeding ceased in each patient during the procedure without any intervention.
COMPARISON OF ESWL WITH LISL
Both randomly assigned groups were comparable with regard to sex, age, number, and location of the bile stones.
Number of fragmentation sessions was more favourable in the LISL group than the ESWL group (Mann-Whitney U test: p=00001). The number of fragmentation pulses was significantly lower for laser fragmentation therapy (p=00053).
Additional endoscopic retrograde cholangiopancreatography sessions were necessary in both treatment groups, although significantly fewer in the LISL group (ESWL 1 6 v LISL 0 65), the difference reaching significance by Mann-Whitney U test (p=0 002).
The stone free rate according to LISL therapy alone was higher than ESWL, but this difference was not significant (Fisher's exact test, p=007). Using a combination of various treatment methods bile ducts were completely freed of stones in 31 of 34 patients (91 2%).
The two groups showed almost identical duration of hospital stay (mean 13-4 v 12-6 days; p=03, NS). The interval between the first treatment session and hospital discharge was significantly shorter for those treated by laser first (3 5 v 6-2 days; p=00002).
An estimated cost analysis was performed based on the costs for lithotripsy sessions, the additional endoscopic retrograde cholangiopancreatography procedures, and the charges for hospital stay. The total charge to the patients in the ESWL group was £4218 and in the LISL group it was £3343; an advantage of about £875 (Table III) for laser therapy. 13 14 In our study stone disintegration through extracorporeal measures was achieved in 12 of 17 patients (71%) but only nine of the 17 patients (52A4%) became stone free after ESWL alone. The number of fragmentation sessions necessary for duct clearance was higher than reported from other study groups including our previously published data using the same lithotripter.7
There are several reasons for our ESWL results being less favourable in this study. The stone properties differ between the published studies. In this trial 11 of the 17 patients treated by ESWL had two or more stones. It is known that the piezoelectric lithotriptor provides only a small focus which does not permit simultaneous fragmentation of more than one stone.7 This problem was also reported in the use of an electrohydraulic ESWL system with a small second shock wave focus. 13 The loss of sonographic visualisation was another major problem. Previous studies have shown that stones in the bile duct could be detected in up to 90% by ultrasound,'5 but the detection rate is lower if there are multiple stones or if stones were located in the upper third of the bile duct.'3 Six patients of the ESWL group in this study had three or more stones and eight of the patients had stones in the upper half of the common bile duct or in the hilum.
The major drawback of ESWL is the time consuming approach in three steps (endoscopic retrograde cholangiopancreatography diagnosis with insertion of a nasobiliary drain, one or more treatment sessions, and finally fragment extraction by endoscopic retrograde cholangiopancreatography). The ESWL equipment is expensive with acquisition costs ranging from about £270 000, but these systems are available at many institutions, because they are widely used by urologists.
Data on laser lithotripsy for complicated bile duct stones has been published from several institutions. For the coumarin green and Nd:YAG laser, stone fragmentation rates of about 80% to 90% were reported, mainly using LISL under direct cholangioscopic control.1658
When performing LISL under fluoroscopic guidance the method failed in up to 80% of patients, in general because positioning of the glass fibre on the stone was difficult. '7 The main advantage of the rhodamine laser used in this trial was the integrated stone tissue detection system. This system allows the treatment to be performed under fluoroscopic control with excellent safety and fragmentation success rates of up to 90%/o.1o 19 20 In this study fluoroscopic guided LISL with the rhodamine 6G laser was effective in clearing the bile ducts in about 80% of the patients of the LISL group and even in two of three patients after failure of ESWL, and there were only minor complications.
To date only two major comparative prospective and randomised studies dealing with intracorporeal and extracorporeal methods for fragmenting retained gall stones have been presented.
In a recently published trial2' 35 patients with complicated bile duct stones were prospectively randomised to ESWL or cholangioscopically controlled electrohydraulic lithotripsy. The study showed a slight but not significant advantage for the electrohydraulic lithotripsy group concerning stone free rate, duration of hospital stay, and hospital charges. In the end both groups were treated comparably efficiently and safely, choledochoscopic electrohydraulic lithotripsy being advantageous considering the number of treatment sessions required.
Neuhaus et al presented a study in 1995 in which radiologically guided ESWL was compared prospectively with laser lithotripsy.22
Although using the rhodamine 6G laser with the automatic stone tissue detection system almost all laser therapies (28 out of 30 patients) were performed under cholangioscopic control and most of the patients were treated via the percutaneous route. LISL was preferable and superior to ESWL under these conditions for the number of treatment sessions (p<O Ol) and the duration of treatment (p<O000l). The stone free rate differed significantly in these circumstances (ESWL 22/30 v LISL 29/30; p<0 05).
As stated above we only found a tendency for fluoroscopic guided ("blind") LISL to be more efficient for duct clearance than sonographic controlled ESWL. This did not reach significance (p=0 07), probably due to the few patients enrolled into the study.
In the LISL group the number of treatment sessions required was significantly lower (p=O000 1) and even the number of additional sessions of endoscopic retrograde cholangiopancreatography after the fragmentation was 
